Banco Santander SA vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Banco Santander SA trades at $13.56 (market cap $192.86B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.36 (market cap $2.27B). The key difference: Banco Santander SA is far larger — about 85× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Banco Santander SA pays a 2.06% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SAN | SLS | |
|---|---|---|
Market Cap | $192.86B | $2.27B |
Volume | 10,644,519 | 4,179,659 |
Sector | Financials | Health |
52-Week High | $15.05 | $15.46 |
52-Week Low | $9.65 | $1.39 |
Typical Hold Time | 55 Days | — |
Enterprise Value | $360.86B | $2.14B |
Dividend Yield | 2.06% | — |
Signals from Pluang's Aura AI — not financial advice
Banco Santander (SAN) trades at $13.66, down 2.5% today, with technical indicators showing bearish momentum. The company reported strong fundamentals with Q2 2026 net income of $14.10 billion and a 26.25% net margin, though cash flow trends show recent operational challenges. Recent developments include the completion of the Webster Financial acquisition, expanding Santander's U.S. presence and diversification.
Outlook remains mixed with analyst consensus at 'Moderate Buy' (64% buy ratings) but technical weakness. Key opportunities include record profitability and strategic acquisitions, while risks involve declining cash flows and high debt levels. The stock's valuation appears reasonable with P/E of 13.55 and P/B of 1.58.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →